Especially relevant in light of their torcetrapib disaster. They’re working on an OTC and spray version of Viagra. That’s just what we need. (via PharmaGossip)
How Pfizer plans to increase revenue
More in Uncategorized
-
Most Popular
Past Week
-
Why your clinic waiting room may affect patient outcomes
Ziya Altug, PT, DPT and Shirish Sachdeva, PT, DPT | Conditions -
The backbone of health care is breaking
Grace Yu, MD | Physician -
Nuclear verdicts and rising costs: How inflation is reshaping medical malpractice claims
Robert E. White, Jr. & The Doctors Company | Policy -
How new loan caps could destroy diversity in medical education
Caleb Andrus-Gazyeva | Policy -
Why transplant equity requires more than access
Zamra Amjid, DHSc, MHA | Policy -
The ethical crossroads of medicine and legislation
M. Bennet Broner, PhD | Conditions
-
Past 6 Months
-
Health equity in Inland Southern California requires urgent action
Vishruth Nagam | Policy -
Why transgender health care needs urgent reform and inclusive practices
Angela Rodriguez, MD | Conditions -
How restrictive opioid policies worsen the crisis
Kayvan Haddadan, MD | Physician -
Why primary care needs better dermatology training
Alex Siauw | Conditions -
New student loan caps could shut low-income students out of medicine
Tom Phan, MD | Physician -
mRNA post vaccination syndrome: Is it real?
Harry Oken, MD | Conditions
-
Recent Posts
-
Why AI in health care needs stronger testing before clinical use [PODCAST]
The Podcast by KevinMD | Podcast -
How AI is reshaping preventive medicine
Jalene Jacob, MD, MBA | Tech -
How transplant recipients can pay it forward through organ donation
Deepak Gupta, MD | Physician -
Inside the high-stakes world of neurosurgery
Isaac Yang, MD | Conditions -
Why I left the clinic to lead health care from the inside
Vandana Maurya, MHA | Conditions -
How doctors can think like CEOs [PODCAST]
The Podcast by KevinMD | Podcast
-
Subscribe to KevinMD and never miss a story!
Get free updates delivered free to your inbox.